The Life Sciences Report: Grant, you’ve been on both the buyside and the sellside. Today you’re an analyst at Zacks, a noninvestment bank firm that does not have to solicit business from the companies on which it performs due diligence and research. Is there an advantage for investors in this research model?
Grant Zeng: Zacks Investment Research is an independent equity research firm. We don’t provide investment banking and other related services to companies we cover. Investors can benefit from this kind of research model because we conduct independent due diligence and research. … [visit site to read more]
Similar posts:- Zacks Analyst Grant Zeng: 6 Biotechs with Staggering Potential The Life Sciences Report: Grant, you’ve been on both the...
- Analyst Scott Power Finds the Upside in Biotech Down Under The Life Sciences Report: Scott, do you get a fair...
- Analyst Bets on Extraordinary Science and Clinical Data: Greg Wade The Life Sciences Report: The Wedbush Management Conference was held...
